Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Armata Pharmaceuticals Inc
TG1NCurrent price
2.02 EUR
0 EUR (0.00%)
Last closed
2.75 USD
Company
www.armatapharma.com
ISIN
US04216R1023
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
84 125 712 USD
Yield for 12 month
+1.49 %
1Y
3Y
5Y
10Y
15Y
TG1N
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc. Address: 5005 McConnell Avenue, Los Angeles, CA, United States, 90066
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7 USDP/E ratio
–Dividend Yield
–Current Year
+4 529 000 USD
Last Year
+5 508 000 USD
Current Quarter
–
Last Quarter
+966 000 USD
Current Year
-29 241 000 USD
Last Year
+4 616 000 USD
Current Quarter
-315 000 USD
Last Quarter
+649 000 USD
Key Figures TG1N
1 year
3 years
5 years
10 years
EBITDA
-40 911 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-25.09 %
PEG Ratio
–
Return On Equity TTM
-3439.35 %
Wall Street Target Price
7 USD
Revenue TTM
3 719 000 USD
Book Value
-1.28 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
21.4 %
Dividend Yield
–
Gross Profit TTM
-29 509 000 USD
Earnings per share
-1.86 USD
Diluted Eps TTM
-1.86 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics TG1N
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TG1N
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:14
Payout Ratio
–
Last Split Date
10.05.2019
Dividend Date
10.05.2019
Stock Valuation TG1N
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
148.1376
Price Sales TTM
22.6205
Enterprise Value EBITDA
-3.4738
Price Book MRQ
4.0597
Financials TG1N
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TG1N
For 52 weeks
1.93 USD
4.48 USD
50 Day MA
2.33 USD
Shares Short Prior Month
5 340
200 Day MA
2.86 USD
Short Ratio
1.08
Shares Short
5 937
Short Percent
0.05 %
BeatStart